Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for MEPOLIZUMAB
- th2 Modulation CRSwNP
- Identifying Predictors Of Response To Mepolizumab In CRSwNP
- The Role of IL5 in Epithelial Cell Integrity
- Symptoms Control and adhErenCe Assessment During Treatment With MepolizUmab New pREfilled Devices
- Evaluate the Pharmacokinetics of BAT2606 Injection in Healthy Chinese Male Subjects
- Immunological Basis for Mepolizumab Activity in COPD
- Efficacy and Safety of Depemokimab Compared With Mepolizumab in Adults With Relapsing or Refractory Eosinophilic Granulomatosis With Polyangiitis (EGPA)
- Open Label, Observational Study for Children & Adolescent With Severe Asthma With an Eosinophilic Phenotype Treated With Mepolizumab
- A Pilot Study of the Use of 129Xe and 1H MRI to Measure the Modulation of Eosinophil-Related Inflammation by Mepolizumab In COPD
- Study of Mepolizumab-based Regimen Compared to Conventional Therapeutic Strategy in Patients With Eosinophilic Granulomatosis With Polyangiitis (E-merge)
- Study in Pediatrics With HypEREosinophilic Syndrome (SPHERE)
- Aggravated Airway Inflammation: Research on Biological Treatment (Mepolizumab)
- Mepolizumab for the Treatment of Chronic Cough With Eosinophilic Airways Diseases
- A Study of GSK3511294 (Depemokimab) Compared With Mepolizumab or Benralizumab in Participants With Severe Asthma With an Eosinophilic Phenotype
- Efficacy and Safety of Mepolizumab in Adults With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)/ Eosinophilic Chronic Rhinosinusitis (ECRS)
- Comparing Treatment Efficacy With Mepolizumab and Omalizumab in Severe Asthma - "Choosebetweenamab".
- Effect of Anti-interleukin 5 (IL5) Therapy on Sputum Cells and Cytokines
- Mepolizumab for Eosinophilic Fasciitis
- Phase 4 Study of Mepolizumab 100 Milligram (mg) Subcutaneous (SC) in Indian Subjects Aged >=18 Years With Severe Eosinophilic Asthma Requiring Maintenance Oral Corticosteroids
- A Pragmatic Study to Investigate the Efficacy and Safety of Mepolizumab in Severe Uncontrolled Asthma in Brazil
- Mepolizumab as Add-on Treatment IN Participants With COPD Characterized by Frequent Exacerbations and Eosinophil Level (MATINEE)
- Acute Exacerbations Treated With BenRAlizumab (The ABRA Study)
- Mepolizumab for COPD Hospital Eosinophilic Admissions Pragmatic Trial
- Mepo for EoE Study
- Inflammation Following Mepolizumab and Oral Corticosteroids in Asthma
- A Safety and Efficacy Study of Mepolizumab in Subjects With Severe Asthma
- Mepolizumab for the Treatment of Chronic Spontaneous Urticaria
- Study of Magnitude and Prediction of Response to Omalizumab and Mepolizumab in Adult Severe Asthma.
- Benralizumab Effect on Severe Chronic Rhinosinusitis With Eosinophilic Polyposis
- A Multi-center, Open-label Extension, Safety Study of Mepolizumab in Subjects With Hypereosinophilic Syndrome (HES) From Study 200622
- Long-term Access Program (LAP) of Mepolizumab for Subjects Who Participated in Study MEA115921
- A Trial of Mepolizumab Adjunctive Therapy for the Prevention of Asthma Exacerbations in Urban Children
- Study of Mepolizumab Autoinjector in Asthmatics
- Effect of Mepolizumab in Severe Bilateral Nasal Polyps
- Efficacy and Safety Study of Mepolizumab in Subjects With Moderate to Severe Atopic Dermatitis
- Study of Mepolizumab Safety Syringe in Asthmatics
- Efficacy and Safety Study of Mepolizumab in Subjects With Severe Hypereosinophilic Syndrome (HES)
- Omalizumab to Mepolizumab Switch Study in Severe Eosinophilic Asthma Patients
- Effects of Mepolizumab Compared to Placebo on Airway Physiology in Patients With Eosinophilic Asthma: MEMORY Study
- Anti-Interleukin-5 (IL5) Monoclonal Antibody (MAb) in Prednisone-dependent Eosinophilic Asthma
- Cessation Versus Continuation of Long-term Mepolizumab in Severe Eosinophilic Asthma Patients
- This Record Contains Information About the Mepolizumab Compassionate Use (CU) Product Activities: 104317: CU and Long-Term Access Study of Mepolizumab in HES. 201956:A Long-term Access Programme for Subjects With Severe Asthma 112562: Expanded Acces
- Pharmacokinetics and Pharmacodynamics of Mepolizumab Administered Subcutaneously in Children
- Cross-sectional Study for Identification and Description of Severe Asthma Patients
- Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Participants With Severe Eosinophilic Asthma on Markers of Asthma Control
- A Phase 3a, Repeat Dose, Open-label, Long-term Safety Study of Mepolizumab in Asthmatic Subjects
- Efficacy and Safety of Mepolizumab as an Add-on Treatment in Chronic Obstructive Pulmonary Disease (COPD)
- Study to Evaluate Efficacy and Safety of Mepolizumab for Frequently Exacerbating Chronic Obstructive Pulmonary Disease (COPD) Patients
- A Study to Investigate Mepolizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis
- Anti-IL-5 Therapy in Bullous Pemphigoid (BP)
- MEA112997 Open-label Long Term Extension Safety Study of Mepolizumab in Asthmatic Subjects
- Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma
- Mepolizumab Steroid-Sparing Study in Subjects With Severe Refractory Asthma
- Mepolizumab Treatment for Rhinovirus-induced Asthma Exacerbations
- Mepolizumab in Chronic Obstructive Pulmonary Diseases (COPD) With Eosinophilic Bronchitis
- Mepolizumab in Nasal Polyposis
- Dose Ranging Efficacy And Safety With Mepolizumab in Severe Asthma
- Safety and Efficacy Study of Mepolizumab in Churg Strauss Syndrome
- Intravenous Mepolizumab In Children With Eosinophilic Esophagitis
- An Evaluation Of Mepolizumab In Therapy Of Eosinophilic Oesophagitis In Adult Patients
- Anti-Interleukin-5 (IL-5) Study for Hypereosinophilic Syndrome
- This Record Contains Information About the Mepolizumab Compassionate Use (CU) Product Activities: 104317: CU and Long-Term Access Study of Mepolizumab in HES. 201956:A Long-term Access Programme for Subjects With Severe Asthma 112562: Expanded Acces
- Open-Label Extension Of Intravenous Mepolizumab In Patients With Hypereosinophilic Syndrome
- Intravenous Mepolizumab In Subjects With Hypereosinophilic Syndromes (HES)
Clinical trials list
click for details